Cargando…
Off‐label prescribing of targeted anticancer therapy at a large pediatric cancer center
BACKGROUND: Off‐label drug prescribing is common in pediatric clinical medicine, though the extent and impact of this practice in pediatric oncology has not yet been characterized. METHODS: We completed a retrospective single‐institution cohort study evaluating prevalence, characteristics, and clini...
Autores principales: | Lim, Mir, Shulman, David S., Roberts, Holly, Li, Anran, Clymer, Jessica, Bona, Kira, Al‐Sayegh, Hasan, Ma, Clement, DuBois, Steven G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520353/ https://www.ncbi.nlm.nih.gov/pubmed/32750219 http://dx.doi.org/10.1002/cam4.3349 |
Ejemplares similares
-
Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology
por: Shulman, David S., et al.
Publicado: (2021) -
Sponsorship of oncology clinical trials in the United States according to age of eligibility
por: Neel, Dylan V., et al.
Publicado: (2020) -
Off-label prescribing for allergic diseases in children
por: Silva, Diana, et al.
Publicado: (2014) -
Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use—Patient Harms and Prescriber Responsibilities
por: Van Norman, Gail A.
Publicado: (2023) -
Off-label prescribing of antipsychotics: prescribing practices and clinical experiences of Finnish physicians
por: Rautio, N., et al.
Publicado: (2022)